AI startup company Anthropic plans to conduct a new round of financing with a valuation potentially reaching 40 billion US dollars.
According to reports, the artificial intelligence (AI) startup company Anthropic is in negotiations for a new round of financing, with a valuation estimated to reach $40 billion.
According to reports, the artificial intelligence (AI) startup company Anthropic is in negotiations for a new round of financing, with a valuation expected to reach $40 billion. It is understood that Anthropic's investors include technology companies such as Alphabet Inc. Class C (GOOGL.US) and Amazon.com, Inc. (AMZN.US).
The report states that Anthropic's financing negotiations are still in the early stages.
Anthropic's competitor OpenAI is also in negotiations for a new round of financing, planning to raise $7 billion, with a valuation of approximately $150 billion.
Amazon.com, Inc. has invested $4 billion in Anthropic, based in San Francisco, including $2.75 billion in March of this year. Other investors include Alphabet Inc. Class C and Salesforce, Inc. (CRM.US).
Earlier this month, Anthropic announced the launch of Siasun Robot & Automation Claude, a generative artificial intelligence chatbot for large enterprises.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025